证券代码：688059 证券简称：华锐精密 公告编号：2026-010 转债代码：118009 转债简称：华锐转债 株洲华锐精密工具股份有限公司 2025年年度业绩预告 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日 （二）业绩预告情况 1、经财务部门初步测算，株洲华锐精密工具股份有限公司（以下简称"公司"）预计2025年度实现归属 于母公司所有者的净利润为18,000.00万元到20,000.00万元，与上年同期相比，将增加7,304.09万元到 9,304.09万元，同比增加68.29%到86.99%。 2、预计2025年度实现归属于母公司所有者的扣除非经常性损益的净利润为17,800.00万元到19,800.00万 元，与上年同期相比，将增加7,368.95万元到9,368.95万元，同比增加70.64%到89.82%。 3、本次业绩预告未经注册会计师审计。 二、上年同期业绩情况与财务状况 （一）利润总额：12,010.24万元。归属于母公司所有者的净利润：10,695.91万元。归属于母公司所有者 的扣除非经常性损益的净利润：10,431.05万元。 （二）每股收 ...

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

（编辑 楚丽君） 证券日报网讯 1月22日，华锐精密发布公告称，投资者所持可转债除在规定时限内通过二级市场继续交 易或按照 61.89元/股的转股价格进行转股外，仅能选择以 100 元/张的票面价格加当期应计利息（即 101.1047 元/张）被强制赎回。若被强制赎回，可能面临较大投资损失。 ...

证券日报网讯1月22日，华锐精密发布公告称，经财务部门初步测算，株洲华锐精密工具股份有限公司 (以下简称"公司")预计2025年度实现归属于母公司所有者的净利润为18，000.00万元到20，000.00万 元，与上年同期相比，将增加7，304.09万元到9，304.09万元，同比增加68.29%到86.99%。 ...

报告期内，下游需求回暖，同时公司产品性能不断提升，品类日趋完善，渠道稳步开拓，产销量同比增 长;同时针对报告期内碳化钨粉等主要原材料价格上涨的情况，公司相应采取涨价措施，产品整体销售 价格有所提升。 华锐精密(688059.SH)披露2025年年度业绩预告，公司预计2025年度实现归属于母公司所有者的净利润 1.8亿元至2亿元，同比增长68.29%到86.99%。预计2025年度实现归属于母公司所有者的扣除非经常性损 益的净利润1.78亿元至1.98亿元，同比增长70.64%到89.82%。 ...

报告期内，下游需求回暖，同时公司产品性能不断提升，品类日趋完善，渠道稳步开拓，产销量同比增 长;同时针对报告期内碳化钨粉等主要原材料价格上涨的情况，公司相应采取涨价措施，产品整体销售 价格有所提升。 智通财经APP讯，华锐精密(688059.SH)披露2025年年度业绩预告，公司预计2025年度实现归属于母公 司所有者的净利润1.8亿元至2亿元，同比增长68.29%到86.99%。预计2025年度实现归属于母公司所有者 的扣除非经常性损益的净利润1.78亿元至1.98亿元，同比增长70.64%到89.82%。 ...

| 证券代码：688059 | 证券简称：华锐精密 | 公告编号：2026-009 | | --- | --- | --- | | 转债代码：118009 | 转债简称：华锐转债 | | 株洲华锐精密工具股份有限公司 关于实施"华锐转债"赎回暨摘牌的第四次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 截至 2026 年 1 月 22 日收市后，距离 2026 年 1 月 28 日（"华锐转债"最后 交易日）仅剩 4 个交易日，2026 年 1 月 28 日为"华锐转债"最后一个交易日。 最后转股日：2026 年 2 月 2 日 截至 2026 年 1 月 22 日收市后，距离 2026 年 2 月 2 日（"华锐转债"最后 转股日）仅剩 7 个交易日，2026 年 2 月 2 日为"华锐转债"最后一个转股日。 本次提前赎回完成后，"华锐转债"将自 2026 年 2 月 3 日起在上海证券 交易所摘牌。 投资者所持可转债除在规定时限内通过二级市场继续交易或按照 61.89 元/股的转股价格进行转 ...

| 证券代码：688059 | 证券简称：华锐精密 | 公告编号：2026-010 | | --- | --- | --- | | 转债代码：118009 | 转债简称：华锐转债 | | 3、本次业绩预告未经注册会计师审计。 二、上年同期业绩情况与财务状况 株洲华锐精密工具股份有限公司 2025 年年度业绩预告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 （二）业绩预告情况 1、经财务部门初步测算，株洲华锐精密工具股份有限公司（以下简称"公 司"）预计 2025 年度实现归属于母公司所有者的净利润为 18,000.00 万元到 20,000.00 万元，与上年同期相比，将增加 7,304.09 万元到 9,304.09 万元，同比 增加 68.29%到 86.99%。 2、预计 2025 年度实现归属于母公司所有者的扣除非经常性损益的净利润为 17,800.00 万元到 19,800.00 万元，与上年同期相比， ...

南财智讯1月22日电，华锐精密发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 18000.00万元—20000.00万元，同比预增68.29%—86.99%；预计2025年全年归属于上市公司股东的扣除 非经常性损益的净利润为17800.00万元—19800.00万元，同比预增70.64%—89.82%，变动原因为：报告 期内，下游需求回暖，同时公司产品性能不断提升，品类日趋完善，渠道稳步开拓，产销量同比增长； 同时针对报告期内碳化钨粉等主要原材料价格上涨的情况，公司相应采取涨价措施，产品整体销售价格 有所提升。报告期内，一方面公司积极践行提质增效行动，加强费用管控，另一方面伴随营业收入增长 带来的规模效应，公司期间费率有所下降。 ...